Onco-Vascular Exer-Study

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

November 2, 2024

Conditions
Breast CancerVascular Disease,PeripheralArterial HypertensionEndothelial DysfunctionMetabolic Disease
Interventions
BEHAVIORAL

Exercise training

"All subjects will participate of 8-weeks of exercise training intervention of concurrent training of high-intensity interval training (HIIT) using stationnaire bikes plus resistance training (RT) using free weight under lab conditions.~The exercise program will be monitored by 8-weeks, adapted individually to each participants in terms of exercise intensity an volume."

Trial Locations (1)

Unknown

ICER-Lab, Talcahuano

All Listed Sponsors
collaborator

Instituto Nacional de Deportes

UNKNOWN

lead

Cristian Alvarez

OTHER

NCT06766903 - Onco-Vascular Exer-Study | Biotech Hunter | Biotech Hunter